Fathom Therapeutics
Fathom Therapeutics is a drug design company combining physics-based simulation with AI.
- 5
- Private company
- New York, NY, USUnited States
Fathom Therapeutics is a drug design company combining physics-based simulation with AI.
Fathom Therapeutics secures **$47 million in Series A funding** to advance its AI-driven drug discovery platform. The company, previously known as Atommap Corp., applies **quantum chemistry and AI** to design novel drug molecules. This funding supports its mission to accelerate therapeutic development through computational methods.
Apr 2026AlphaMavenNews article
Fathom Therapeutics secures $47 million in an oversubscribed Series A round to advance AI-driven small molecule drug discovery. The company applies physics-based modeling to design next-generation medicines, leveraging computational approaches for therapeutic development.
Apr 2026MarketScreenerNews article
Fathom Therapeutics secures **$47 million in Series A funding** to advance its drug discovery platform, which combines **quantum chemistry and AI** to design new molecular compounds. The New York City-based company, formerly known as Atommap Corp, leverages computational methods to accelerate the development of novel therapeutics. Investors back the approach’s potential to transform traditional pharmaceutical R&D pipelines.
Apr 2026FinSMEsNews article
Fathom Therapeutics secures $47 million in an oversubscribed Series A round to advance its AI and quantum chemistry platform for designing novel small-molecule drugs. The company leverages predictive modeling to create next-generation medicines, targeting unmet therapeutic needs. Backers include investors eager to translate physics-based computational approaches into clinical applications.
Apr 2026PR NewswireNews article